These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 14127811)
1. [POSSIBILITIES OF ORAL DIABETES THERAPY]. MEHNERT H; MAHRHOFER E; KAISER W Ther Ggw; 1964 Jan; 103():21-33. PubMed ID: 14127811 [No Abstract] [Full Text] [Related]
2. [ORAL THERAPY OF DIABETES MELLITUS]. MOHNIKE G Cas Lek Cesk; 1964 Mar; 103():305-11. PubMed ID: 14138939 [No Abstract] [Full Text] [Related]
3. [OUR EXPERIENCES WITH ORAL ANTIDIABETICS IN OUTPATIENT CONTROL AND TREATMENT OF DIABETIC PATIENTS]. ANGELI I Orv Hetil; 1964 Nov; 105():2186-90. PubMed ID: 14216805 [No Abstract] [Full Text] [Related]
5. [STUDIES ON THE PROBLEM OF THE SO-CALLED LATE FAILURE OF SULFONYLUREA THERAPY]. MEHNERT H; REISNER E Dtsch Med Wochenschr; 1964 Jul; 89():1378-84. PubMed ID: 14160351 [No Abstract] [Full Text] [Related]
6. LONG-TERM OBSERVATIONS ON ORAL HYPOGLYCEMIC AGENTS IN DIABETES; THE EFFECT OF CARBUTAMIDE AND TOLBUTAMIDE. BERNHARD H Diabetes; 1965 Feb; 14():59-70. PubMed ID: 14256053 [No Abstract] [Full Text] [Related]
7. THE MODERN MANAGEMENT OF DIABETES MELLITUS. GHALIOUNGI P J Egypt Med Assoc; 1963; 46():705-16. PubMed ID: 14083182 [No Abstract] [Full Text] [Related]
8. [EXPERIMENTAL BASIS FOR COMBINED TREATMENT OF DIABETES WITH THE BIGUANIDE-SULFONAMIDE ASSOCIATION]. STERNE J; HIRSCH C Diabete; 1964; 12():171-5. PubMed ID: 14173920 [No Abstract] [Full Text] [Related]
9. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE]. KLINGER R; DALLECOSTE P Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829 [No Abstract] [Full Text] [Related]
13. OBSERVATIONS ON CLINICAL PATTERNS OF DIABETES MELLITUS IN INDIA. TRIPATHY BB; KAR BC Diabetes; 1965 Jul; 14():404-12. PubMed ID: 14318588 [No Abstract] [Full Text] [Related]
14. [ON THE PROBLEM OF LIMITED EFFECTIVENESS OF SULFANYLUREA THERAPY IN DIABETES MELLITUS]. LUSCHNITZ E; SEIGE K; MUEHLBERG H Z Gesamte Inn Med; 1965 Jan; 20():SUPPL:255-6 C. PubMed ID: 14262358 [No Abstract] [Full Text] [Related]
15. CARBUTAMIDE and tolbutamide in the treatment of diabetes. Med J Aust; 1957 Dec; 44(24):865-6. PubMed ID: 13492803 [No Abstract] [Full Text] [Related]
16. [ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)]. BERNHARD H Arzneimittelforschung; 1964 May; 14():411-2. PubMed ID: 14238602 [No Abstract] [Full Text] [Related]
17. [CLINICAL STUDIES OF THE EFFECTS OF ORAL ANTIDIABETICS IN THE FETUS]. STERNE J; LAVIEUVILLE M Diabete; 1963; 11():292-4. PubMed ID: 14082976 [No Abstract] [Full Text] [Related]
18. LONG-TERM CHLORPROPAMIDE THERAPY IN DIABETES: FOUR YEARS' EXPERIENCE. EVANS JR; EVANS BR; EVANS GR J Am Geriatr Soc; 1964 Feb; 12():195-201. PubMed ID: 14118834 [No Abstract] [Full Text] [Related]
19. [TREATMENT OF DIABETES MELLITUS WITH SULFANILAMIDE PREPARATIONS]. DOZORETS IL; SELEZNEV LE Zdravookhr Beloruss; 1964 Jan; 10():68-71. PubMed ID: 14180048 [No Abstract] [Full Text] [Related]
20. A REVIEW OF THE HISTORY OF THE TREATMENT OF DIABETES MELLITUS AND THE SEARCH FOR ORAL HYPOGLYCAEMIC AGENTS. PADFIELD CJ Guys Hosp Rep; 1964; 113():45-54. PubMed ID: 14114729 [No Abstract] [Full Text] [Related] [Next] [New Search]